Telix Pharmaceuticals provides updates on their precision medicine portfolio, including positive Phase 3 data for TLX591-CDx in Chinese patients. The study met the primary endpoint of patient-level positive predictive value for tumor detection in prostate cancer patients. More than two-thirds of patients had a change in treatment plan based on PSMA-PET imaging results. Telix is also progressing well with their TLX101-CDx and TLX250-CDx FDA resubmissions. TLX250-CDx received positive feedback from the FDA regarding remediation of identified deficiencies. Telix remains committed to serving patients through their Expanded Access Program for both products. TLX250-CDx is Telix’s PET imaging candidate for diagnosing and characterizing clear cell renal cell carcinoma, the most common kidney cancer subtype. TLX101-CDx and TLX250-CDx have not received marketing authorization in any jurisdiction. Telix Pharmaceuticals is providing further information on their website and social media platforms. Contact Telix Investor Relations for more details. This announcement has been authorized by the Telix Pharmaceuticals Limited Disclosure Committee. Be cautious when reading forward-looking statements and consult official reports for accurate information. Telix’s trademarks and trade names are protected. 1. In a groundbreaking study, researchers have discovered a new potential treatment for Alzheimer’s disease. The drug, known as Aducanumab, has shown promising results in slowing down cognitive decline in patients with early-stage Alzheimer’s.

2. The stock market experienced a sharp decline today, with the Dow Jones Industrial Average dropping 500 points. Investors are concerned about rising inflation rates and uncertainty surrounding global trade tensions.

3. A severe heatwave is sweeping across the western United States, with temperatures reaching record highs in several states. Officials are urging residents to stay hydrated and take precautions to avoid heat-related illnesses.

4. The World Health Organization has declared the Ebola outbreak in the Democratic Republic of Congo a global health emergency. The outbreak has claimed over 1,600 lives and continues to spread, posing a significant threat to public health.

5. Tesla has announced plans to open a new Gigafactory in Shanghai, China. The electric car company aims to increase production capacity and meet growing demand for its vehicles in the Chinese market.

Read more at 1. Global warming accelerates as latest data shows 2020 tied for hottest year on record. – Reuters

2. Tech giant Apple reports record-breaking revenue of $111.4 billion in Q1, surpassing analyst expectations. – CNBC

3. Pfizer-BioNTech vaccine found to be 95% effective in preventing COVID-19 in real-world conditions, according to new study. – Wall Street Journal

4. Tesla stocks surge 20% after company announces plans to expand production capacity with new factory in Texas. – CBS MarketWatch

5. Amazon CEO Jeff Bezos steps down, handing over leadership to Andy Jassy as company continues to dominate e-commerce market. – Barchart: Precision Medicine Portfolio Update: Illuccix China Phase 3